Skip to nav Skip to content
Lary  Robinson

Lary Robinson, MD

5 (290)

Specialty: Thoracic Surgery

Program: Thoracic Oncology

  • Overview

    Cancer Focus:
    Lung Cancer, Mesothelioma, Pancoast Tumor, Thymoma

    Dr. Robinson, a native of Kansas, received his undergraduate B.A. degree in anthropology at the University of Kansas and his medical degree from the Washington University School of Medicine in St. Louis, Missouri. He completed his internship and residency in general and cardiothoracic surgery at the Duke University Medical Center. Additionally, he completed a fellowship in cardiac research and clinical cardiac surgery at the St. Thomas’ Hospital in London. He also served as a Flight Surgeon at the rank of Major, USAF in Thailand during the Vietnam War.  A Diplomat of the American Board of Surgery, the American Board of Thoracic Surgery as well as certified in Surgical Critical Care, Dr. Robinson began his practice at the University of Nebraska Medical Center where he was an Associate Professor of Surgery and Pharmacology and the Clinical Director of the Clinical Perfusion Science Education Program. Dr. Robinson then came to the University of South Florida College of Medicine in Tampa in 1994 where he is currently a Professor of Surgery (Thoracic) and Interdisciplinary Oncology. He practices thoracic surgical oncology at the Moffitt Cancer Center as a Senior Member with Tenure of the Moffitt Medical Group. He is also Director of the Pancoast Tumor Program in the Department of Thoracic Oncology. He also helped found the Center for Infection Research in Cancer (CIRC) in 2012.  He is also the co-founder and President of Prelude to a Cure, Inc., a non-profit charity dedicated to raising funds to support lung cancer research. Finally, he is the Director of the new Lung Cancer Early Detection Center at Moffitt. Dr. Robinson is the author or co-author of over 160 medical publications. He is directly involved as Principal Investigator in 3 ongoing clinical cancer research protocols involving lung cancer and the microbiome, lung cancer in never-smoking women and the use of biomarkers for diagnosis, risk stratification and long-term surveillance of lung cancer. He is also Principal Investigator for a prospective multi-center clinical study evaluating the influence of the gut microbiome on the effectiveness of immunotherapy for advanced lung cancer. Clinically, he is a member of the multidisciplinary thoracic oncology group involved in the evaluation and treatment of all stages of lung cancer, thymoma, and other thoracic cancers which includes aggressive, combined modality therapy including numerous clinical trials. 

    Education & Training

    Fellowship:

    • Duke University Medical Center - Surgery Research
    • St. Thomas' Hospital, London - Cardiac Surgery
    • Duke University Medical Center - Cardiac Surgery

    Residency:

    • Duke University Medical Center - General & Thoracic Surgery

    Medical School:

    • Washington University School of Medicine - MD
  • Participating Trials

    Clinical Trial 21767
    Phase 2: Using Biomarkers for Diagnosis, Risk Stratification of Post-Treatment Recurrence and Long-Term Surveillance of Lung Cancer
    Condition: Thoracic
    Intervention: AZD9291 (Osimertinib); Osimertinib ()
    Status: Open

    If you believe you are eligible for one of these trials or studies, please call
    813-745-6100 or toll-free 1-800-679-0775.

  • Publications

    • Wang C, Ma A, Li Y, McNutt ME, Zhang S, Zhu J, Hoyd R, Wheeler CE, Robinson LA, Chan CHF, Zakharia Y, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Singer EA, Ikeguchi AP, McCarter MD, Denko N, Tinoco G, Husain M, Jin N, Osman AEG, Eljilany I, Tan AC, Coleman SS, Denko L, Riedlinger G, Schneider BP, Spakowicz D, Ma Q. A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset. Cancer Res Commun. 2024 Feb.4(2):293-302. Pubmedid: 38259095. Pmcid: PMC10840455.
    • Abdelghany K, Robinson LA, Tanvetyanon T. Impact of Robotic-Assisted Thoracic Surgery on the Completion of Adjuvant Chemotherapy Following Lung Cancer Resection. Cureus. 2022 Oct.14(10):e30364. Pubmedid: 36407249. Pmcid: PMC9665910.
    • Zhang Y, Seminario-Vidal L, Cohen L, Hussaini M, Yao J, Rutenberg D, Kim Y, Giuliano A, Robinson LA, Sokol L. "Alterations in the Skin Microbiota Are Associated With Symptom Severity in Mycosis Fungoides". Front Cell Infect Microbiol. 2022 May.12:850509. Pubmedid: 35656034. Pmcid: PMC9152451.
    • Newsome RC, Gharaibeh RZ, Pierce CM, da Silva WV, Paul S, Hogue SR, Yu Q, Antonia S, Conejo-Garcia JR, Robinson LA, Jobin C. Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort. Genome Med. 2022 Mar.14(1):35. Pubmedid: 35346337. Pmcid: PMC8961902.
    • Robinson LA, Fontaine J, El-Haddad G, Bryant S, Perez B, Toloza E, Kis B. Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. Ann Thorac Surg. 2022 Jan.113(1):e29-e31. Pubmedid: 33794166.
    • Nyein AF, Bari S, Hogue S, Zhao Y, Maller B, Sha S, Gomez MF, Rollison DE, Robinson LA. Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer. BMC Cancer. 2022 Jan.22(1):101. Pubmedid: 35073876. Pmcid: PMC8787935.
    • Robinson LA, Tanvetyanon T, Grubbs D, Robinson NA, Pierce CM, McCarthy K, Garcia-Getting R, Patel S. Preoperative nutrition-enhanced recovery after surgery protocol for thoracic neoplasms. J Thorac Cardiovasc Surg. 2021 Sep.162(3):710-720.e1. Pubmedid: 32713631.
    • Robinson LA. Dog Ownership Is the Best Preventive 'Medicine' for Patients. Am J Med. 2021 Jun.134(6):710-712. Pubmedid: 33621539.
    • Robinson LA, Babacan NA, Tanvetyanon T, Henderson-Jackson E, Bui MM, Druta M. Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas. J Thorac Cardiovasc Surg. 2021 Jul.162(1):274-284. Pubmedid: 32711968.
    • Robinson LA, Pierce CM. Is 'inflammaging' fuelling severe COVID-19 disease?. J R Soc Med. 2020 Sep.113(9):346-349. Pubmedid: 32910875. Pmcid: PMC7488938.
    • Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F. Reply to Dickhoff et al. from authors of 'Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer'. Lung Cancer. 2018 Oct.124:322-323. Pubmedid: 30193907.
    • Shafique MR, Robinson LA, Antonia S. Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer. Cancer Manag Res. 2018 May.10:931-940. Pubmedid: 29760563. Pmcid: PMC5937504.
    • Baldonado JJAR, Amaral M, Garrett J, Moodie C, Robinson L, Keenan R, Toloza EM, Fontaine JP. Credentialing for robotic lobectomy: what is the learning curve? A retrospective analysis of 272 consecutive cases by a single surgeon. J Robot Surg. 2018 Dec.13(5):663-669. Pubmedid: 30560496.
    • Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F. Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer. Lung Cancer. 2018 Aug.122:206-213. Pubmedid: 30032833.
    • Kim Y, Pierce CM, Robinson LA. Impact of viral presence in tumor on gene expression in non-small cell lung cancer. BMC Cancer. 2018 Aug.18(1):843. Pubmedid: 30134863. Pmcid: PMC6106745.
    • Robinson LA, Seshi B, Chervenick PA. "False" aortic dissection. Asian Cardiovasc Thorac Ann. 2017 Jan.25(1):76-77. Pubmedid: 26124435.
    • Mills M, Choi J, El-Haddad G, Sweeney J, Biebel B, Robinson L, Antonia S, Kumar A, Kis B. Retrospective analysis of technical success rate and procedure-related complications of 867 percutaneous CT-guided needle biopsies of lung lesions. Clin Radiol. 2017 Dec.72(12):1038-1046. Pubmedid: 28851490.
    • Robinson LA, Jaing CJ, Campbell CP, Magliocco A, Xiong Y, Magliocco G, Thissen JB, Antonia S. Reply to: Comment on 'Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung'. Brit J Cancer. 2017 01.116(3):e6. Pubmedid: 27764846. Pmcid: PMC5294469.
    • Nguyen DT, Fontaine JP, Robinson LA, Keenan RJ, Toloza EM. P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S195. Pubmedid: 27676508.
    • Nguyen DT, Fontaine JP, Robinson LA, Keenan RJ, Toloza EM. P1.17: Improved Survival for Stage-2 (N1) Pulmonary Adenocarcinoma and Squamous Cell Carcinoma After Pulmonary Lobectomy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S191-S192. Pubmedid: 27676503.
    • Robinson LA, Tanvetyanon T, Springett G, Fontaine J, Toloza E, Hodul P, Pimiento JM, Malafa M. Pulmonary metastasectomy for suspected pancreaticobiliary cancer. J Thorac Cardiovasc Surg. 2016 Jul.152(1):75-82. Pubmedid: 27050555.
    • Filis AK, Robinson LA, Vrionis FD. Resection of the First Rib With Preservation of the T1 Nerve Root in Pancoast Tumors of the Lung. Cancer Control. 2016 Jul.23(3):295-301. Pubmedid: 27556670.
    • Echavarria MF, Cheng AM, Velez-Cubian FO, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Robinson LA, Toloza EM. Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy. Am J Surg. 2016 Dec.212(6):1175-1182. Pubmedid: 27823756.
    • Robinson LA, Jaing CJ, Pierce Campbell C, Magliocco A, Xiong Y, Magliocco G, Thissen JB, Antonia S. Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Brit J Cancer. 2016 Aug.115(4):497-504. Pubmedid: 27415011. Pmcid: PMC4985355.
    • Robinson LA, Grubbs DM. Using "Rebar" to Stabilize Rigid Chest Wall Reconstruction. Thorac Cardiovasc Surg. 2016 Apr.64(3):266-269. Pubmedid: 25602843.
    • DeVito N, Henderson E, Han G, Reed D, Bui MM, Lavey R, Robinson L, Zager JS, Gonzalez RJ, Sondak VK, Letson GD, Conley A. Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience. PLoS One. 2015 Oct.10(10):e0140362. Pubmedid: 26469269. Pmcid: PMC4607370.
    • Dossett LA, Toloza EM, Fontaine J, Robinson LA, Reed D, Druta M, Letson DG, Zager JS, Gonzalez RJ. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma. J Surg Oncol. 2015 Jul.112(1):103-106. Pubmedid: 26179670.
    • Tanvetyanon T, Finley DJ, Fabian T, Riquet M, Voltolini L, Kocaturk C, Bryant A, Robinson L. Prognostic nomogram to predict survival after surgery for synchronous multiple lung cancers in multiple lobes. J Thorac Oncol. 2015 Feb.10(2):338-345. Pubmedid: 25330145.
    • Rodriguez K, Velez-Cubian F, Zhang WW, Tanvetyanon T, Thau M, Moodie C, Garrett J, Fontaine JP, Robinson L, Toloza E. Effects of pulmonary function and of smoking history on perioperative outcomes after robotic-assisted pulmonary lobectomy: retrospective analysis of 201 consecutive patients. Chest. 2014 Mar.145(3 Suppl):48A. Pubmedid: 24638644.
    • Velez-Cubian F, Zhang WW, Rodriguez K, Thau M, Moodie C, Garrett J, Fontaine JP, Robinson L, Toloza E. Efficacy of Lymph Node Dissection During Robotic-Assisted Pulmonary Lobectomy for Non-small Cell Lung Cancer: Retrospective Analysis of 159 Consecutive Cases. Chest. 2014 Mar.145(3 Suppl):56A. Pubmedid: 24638719.
    • Downs JB, Robinson LA, Steighner ML, Thrush D, Reich RR, Räsänen JO. "Open lung ventilation optimizes pulmonary function during lung surgery". J Surg Res. 2014 Dec.192(2):242-249. Pubmedid: 25033701.
    • Setzer M, Robinson LA, Vrionis FD. Management of locally advanced pancoast (superior sulcus) tumors with spine involvement. Cancer Control. 2014 Apr.21(2):158-167. Pubmedid: 24667403.
    • Robinson LA, Smith P, Sengupta DJ, Prentice JL, Sandin RL. Molecular analysis of sarcoidosis lymph nodes for microorganisms: a case-control study with clinical correlates. BMJ Open. 2013 Dec.3(12):e004065. Pubmedid: 24366580. Pmcid: PMC3884606.
    • Tanvetyanon T, Finley DJ, Fabian T, Riquet M, Voltolini L, Kocaturk C, Fulp WJ, Cerfolio RJ, Park BJ, Robinson LA. Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data. Ann Oncol. 2013 Apr.24(4):889-894. Pubmedid: 23136230.
    • Tanvetyanon T, Robinson L, Sommers KE, Haura E, Kim J, Altiok S, Bepler G. Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers. J Thorac Oncol. 2010 Jul.5(7):1018-1024. Pubmedid: 20453687.
    • Gray J, Sommers E, Alvelo-Rivera M, Robinson L, Bepler G. Neoadjuvant chemotherapy for resectable non-small-cell lung cancer. Oncology (Williston Park). 2009 Sep.23(10):879-886. Pubmedid: 19839429.
    • Bepler G, Sommers KE, Cantor A, Li X, Sharma A, Williams C, Chiappori A, Haura E, Antonia S, Tanvetyanon T, Simon G, Obasaju C, Robinson LA. Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer. J Thorac Oncol. 2008 Oct.3(10):1112-1118. Pubmedid: 18827606. Pmcid: PMC2639211.
    • Tanvetyanon T, Eikman EA, Sommers E, Robinson L, Boulware D, Bepler G. Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer. J Clin Oncol. 2008 Oct.26(28):4610-4616. Pubmedid: 18824709.
    • Zheng Z, Li X, Schell M, Chen T, Boulware D, Robinson L, Sommers E, Bepler G. Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. Cancer. 2008 Jun.112(12):2765-2773. Pubmedid: 18442042. Pmcid: PMC3857609.
    • Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep.132(3 Suppl):243S-265S. Pubmedid: 17873172.
    • Robinson LA. Solitary fibrous tumor of the pleura. Cancer Control. 2006 Oct.13(4):264-269. Pubmedid: 17075563.
    • Ramnath N, Sommers E, Robinson L, Nwogu C, Sharma A, Cantor A, Bepler G. Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer. Chest. 2005 Nov.128(5):3467-3474. Pubmedid: 16304301.
    • Coppage L, Sroufe A, Robinson L. Imaging in oncology: chest mass. Cancer Control. 2005 Apr.12(2):126, 137-126, 139. Pubmedid: 16013100.
    • Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. J Clin Oncol. 2004 May.22(10):1878-1885. Pubmedid: 15143080.
    • Simon G, Ruckdeschel J, Williams C, Cantor A, Antonia S, Haura E, Rocha C, Chiappori A, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution. Cancer Control. 2003 Sep.10(5):388-395. Pubmedid: 14581894.
    • Riedel BW, Robinson LA, Klesges RC, McLain-Allen B. Ethnic differences in smoking withdrawal effects among adolescents. Addictive Behaviors. 2003 Jan.28(1):129-140. Pubmedid: 12507532.
    • Thurman S, Robinson L, Ahmad N, Pow-Sang J, Lockhart J, Seigne J. Investigation of the safety and accuracy of intraoperative gamma probe directed biopsy of bone scan detected rib abnormalities in prostatic adenocarcinoma. J Urol. 2003 Apr.169(4):1341-1344. Pubmedid: 12629356.
    • Robinson L. Invited commentary. Ann Thorac Surg. 2003.76:1853-1853. Pubmedid: 14667598.
    • Strickland-Marmol L, Khoor A, Robinson L, Williams CC J. Malignant localized fibrous tumor of the pleura. Cancer Control. 2002 May.9(3):255-258. Pubmedid: 12060824.
    • Robinson LA. Radio-guided surgical biopsy for the diagnosis of suspected osseous metastases. Q J Nucl Med. 2001 Mar.45(1):38-46. Pubmedid: 11456374.
    • Garland L, Robinson L, Wagner H. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer. Chest Surg Clin N Am. 2001 Feb.11(1):69-100, viii. Pubmedid: 11253602.
    • Bosek V, Hu P, Robinson L. Acute myocardial ischemia after administration of ondansetron hydrochloride. Anesthesiology. 2000 Mar.92(3):885-887. Pubmedid: 10719974.
    • Robinson LA. Top ten list in lung cancer. Chest. 2000 Jul.118(1):228-229. Pubmedid: 10893383.
    • Robinson LA. Bone localization. Surg Oncol Clin N Am. 1999 Jul.8(3):565-76, xi. Pubmedid: 10448698.
    • Sunday R, Robinson L, Bosek V. Low cardiac output complicating pericardiectomy for pericardial tamponade. Ann Thorac Surg. 1999 Jan.67(1):228-231. Pubmedid: 10086556.
    • Robinson LA. Aspergillus and other fungi. Chest Surg Clin N Am. 1999 Feb.9(1):193-225, x. Pubmedid: 10079987.
    • Castellano M, Greene J, Robinson L, Sandin R, Muro-Cacho C. Pulmonary pseudo-aneurysm due to aspergillus fumigatus in a breast cancer patient. Infect Med. 1999.16(3):201-204.
    • Robinson L, Preksto D, Muro-Cacho C, Hubbell D. Intraoperative gamma probe-directed biopsy of asymptomatic suspected bone metastases. Ann Thorac Surg. 1998 May.65(5):1426-1432. Pubmedid: 9594879.
    • Venugopal P, Berman C, Robinson L. The Pleural Tent. Cancer Control. 1998 Jan.5(1):41. Pubmedid: 10761016.
    • Robinson LA, Preksto D. Pleural tenting during upper lobectomy decreases chest tube time and total hospitalization days. J Thorac Cardiovasc Surg. 1998 Feb.115(2):319-326. Pubmedid: 9475526.
    • Bosek V, Robinson L. Postoperative complications of pneumonectomy. Curr Rev Nurse Anesth. 1998.20:166-179.
    • Bosek V, Robinson L. Complications of pneumonectomy. Curr Rev Perianesth Nurse. 1998.20:2-15.
    • Robinson L. Radioisotope-Guided Surgical Biopsy of Suspected Osseous Metastases. Cancer Control. 1997 Nov.4(6):516-522. Pubmedid: 10763060.
    • Venkattaramanabalaji G, Foster D, Greene J, Muro-Cacho C, Sandin R, Saez R, Robinson L. Mucormycosis Associated With Deferoxamine Therapy After allogeneic Bone Marrow Transplantation. Cancer Control. 1997 Mar.4(2):168-171. Pubmedid: 10763015.
    • Robinson LA, Rolfe MW. "Keeling" syndrome--a late complication of pneumonectomy. N Engl J Med. 1996 10.335(14):1074. Pubmedid: 8801458.
    • Ruckdeschel J, Wagner, Jr. H, Robinson L. Locally advanced lung cancer: controversies in management. Adv Oncol. 1996.12(3):22-28.
    • Robinson L, Dobson J, Biermann P. Fallibility of transthoracic needle biopsy of anterior mediastinal masses. Thorax. 1995 Oct.50(10):1114-1116. Pubmedid: 7491564. Pmcid: PMC475029.
    • Holcombe BJ, Thorn DB, Strausburg KM, Ponto JA, Caiola SM, Powers T, Bertino JS, Leitinger EA, Robinson LA. Analysis of the practice of nutrition support pharmacy specialists. Pharmacotherapy. 1995 Nov.15(6):806-813. Pubmedid: 8602394.
    • Robinson L, Reed E, Galbraith T, Alonso A, Moulton A, Fleming W. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg. 1995 Jun.109(6):1182-1196. Pubmedid: 7776682.
    • Robinson L, Schwarz G, Goddard D, Fleming W, Galbraith T. Myocardial protection for acquired heart disease surgery: results of a national survey. Ann Thorac Surg. 1995 Feb.59(2):361-372. Pubmedid: 7847950.
    • Robinson L, Smith L, Fontaine M, Kay H, Mountjoy C, Pirriccello S. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Ann Thorac Surg. 1995 Dec.60(6):1583-1591. Pubmedid: 8787447.
    • Antonia S, Wagner, Jr. H, Williams, Jr. C, Alberts W, Hubbell D, Robinson L, Hilstro J, Ruckdeschel J. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. Semin Oncol. 1995 Aug.22(4 Suppl 9):34-37. Pubmedid: 7644926.
    • Hunt A, Stammers A, Robinson L. Antegrade versus retrograde cardioplegia for low risk coronary artery bypass surgery: a comparative study. J Extra Corpor Tech. 1995.27:70-76. Pubmedid: noPMID.
    • Robinson LA, Windle JR, Easley AR. Options in managing the patient with high defibrillation thresholds. Ann Thorac Surg. 1994 May.57(5):1184-1192. Pubmedid: 8179383.
    • Robinson LA, Windle JR. Defibrillator twiddler's syndrome. Ann Thorac Surg. 1994 Jul.58(1):247-249. Pubmedid: 8037540.
    • Robinson LA. Angiogenesis and low molecular weight heparin. J Am Coll Cardiol. 1994 Jul.24(1):272-274. Pubmedid: 7516353.
    • Robinson LA, Moulton AL, Fleming WH. Techniques to simplify esophagogastric circular stapled anastomoses. J Surg Oncol. 1994 Dec.57(4):266-269. Pubmedid: 7990483.
    • Robinson LA, Rikkers LF, Dobson JR. Benign mediastinal teratoma masquerading as a large multiloculated effusion. Ann Thorac Surg. 1994 Aug.58(2):545-548. Pubmedid: 8067862.
    • Robinson LA, Moulton AL, Fleming WH, Alonso A, Galbraith TA. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Ann Thorac Surg. 1994 Apr.57(4):803-813. Pubmedid: 8166523.
    • Robinson L, Windle J. Defibrillator Twiddler's syndrome. Ann Thorac Surg. 1994.58:247-249.
    • Robinson L, Windle J, Easley A. Options in managing the high defibrillation threshold patient. Ann Thorac Surg. 1994.57:1184-1192.
    • Robinson L, Moulton A, Fleming W. Techniques to simplify esophagogastric circular stapled anastomoses. J Surg Oncol. 1994.57:266-269.
    • Robinson L, Rikkers L, Dobson J. Benign mediastinal teratoma masquerading as a large multiloculated effusion. Ann Thorac Surg. 1994.58:545-548.
    • Robinson L, Reilly R. Localized pleural mesothelioma: the clinical spectrum. Chest. 1994.106:1611-1615.
    • Robinson L, Moulton A, Fleming W, Alonso A, Galbraith T. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Ann Thorac Surg. 1994.57:803-814.
    • Robinson LA. Adenosine triphosphate enhancement of postischemic function in immature myocardium. Chest. 1993 Sep.104(3):984-985. Pubmedid: 8365338.
    • Robinson LA, Fleming WH, Galbraith TA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg. 1993 May.55(5):1115-1121. Pubmedid: 8494419.
    • Robinson LA. Cavernous hemangioma of the intercostal space. Ann Thorac Surg. 1993 Apr.55(4):1052-1054. Pubmedid: 8466329.
    • Robinson L, Fleming W, Galbraith T. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg. 1993.55:1115-1122.
    • Robinson LA, Harwood DL. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia. J Thorac Cardiovasc Surg. 1991 Feb.101(2):314-325. Pubmedid: 1992242.
    • Fleming WH, Sarafian LB, Moulton AL, Robinson LA, Kugler JD. Valve replacement in the right side of the heart in children: long-term follow-up. Ann Thorac Surg. 1989 Sep.48(3):404-408. Pubmedid: 2774727.
    • Halperin ML, Margolis BL, Robinson LA, Halperin RM, West ML, Bear RA. The urine osmolal gap: a clue to estimate urine ammonium in "hybrid" types of metabolic acidosis. Clin Invest Med. 1988 Jun.11(3):198-202. Pubmedid: 3135965.
    • Weiss VC, West DP, Ackerman R, Robinson LA. Hepatotoxic reactions in a patient treated with etretinate. Arch Dermatol. 1984 Jan.120(1):104-106. Pubmedid: 6691707.
    • Robinson LA, Braimbridge MV, Hearse DJ. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia. J Thorac Cardiovasc Surg. 1984 Feb.87(2):190-200. Pubmedid: 6694410.
    • Weiss VC, West DP, Fu TS, Robinson LA, Cook B, Cohen RL, Chambers DA. Alopecia areata treated with topical minoxidil. Arch Dermatol. 1984 Apr.120(4):457-463. Pubmedid: 6703751.
    • Robinson LA, Wright BT. Comment on intravenous nitroglycerin. Drug Intell Clin Pharm. 1983 Jan.17(1):49. Pubmedid: 6402349.
    • Robinson LA, Sabiston DC. Syndrome of congenital internal mammary-to-pulmonary arteriovenous fistula associated with mitral valve prolapse. Arch Surg. 1981 Oct.116(10):1265-1273. Pubmedid: 7283701.
    • Brada M, Robinson LA, Bellingham AJ. The effect of methylprednisolone sodium succinate on erythrocyte and haemoglobin function. Clin Sci (Lond). 1980 Sep.59(3):163-168. Pubmedid: 7000416.
    • Vanderveen TW, Robinson LA, Ray MD. Etiological factors of the Stevens-Johnson syndrome. Am J Hosp Pharm. 1975 Nov.32(11):1149-1153. Pubmedid: 1190237.
    • Robinson L, Ruckdeschel J. Management of pleural and pericardial effusions. In: Berger A, Portenoy R, Weissman D, et al, eds. Principles and practice of supportive oncology. 1st ed. PA: J.B. Lippincott Company; 1998;327-353.
    • Robinson L. Aspergillus and other fungi. In: Robinson L, ed. Thoracic disorders in the immunocompromised patient (Chest surgery clinics of North America V. 9). 1st ed. Philadelphia, PA: W.B. Saunders; 1999;193-226.
    • Walsh F, Rolfe W, Rumbak M. The initial evaluation of the immunocompromised patient. In: Robinson L, ed. Thoracic Disorders in the Immunocompromised Patient. Philadelphia, PA: W. B. Saunders; 1999.
    • Thompson A, Floreani A, Robinson L, Shure D, Rennard S. Diagnostic procedures: pulmonary parenchyma and others. In: Baum G, Wolinsky E, eds. Textbook of Pulmonary Diseases. 5th ed. Boston, MA: Little, Brown And Company; 1994;343-365.
    • Robinson L. Bone localization. In: Reintgen D, ed. Radioguided surgery (surgical oncology clinics of north america). 1st ed. PA: W.B. Saunders; 1999;565-576.
    • Floreani A, Robinson L, Rennard S, Thompson A. Diagnostic techniques: the pleura. In: Baum G, Wolinsky E, eds. Textbook of Pulmonary Diseases. 5th ed. Boston, MA: Little, Brown And Company; 1994;367-378.
    • Antonia S, Robinson L, Ruckdeschel J, Wagner, Jr. H. Lung cancer treatment in the older patient. In: Balducci L, Lyman G, Ershler W, et al, eds. Comprehensive geriatric oncology. 2 ed. London. Harwood Academic Publishers; 1998;611-628.
    • Robinson L. Bone lesion localization. In: Witman E, Reintgen D, eds. Handbook of sentinel lymph node mapping biopsy. 1st ed. Austin, TX: R.G. Landes; 1999;154-163.
  • Patient Comments

    Overall Satisfaction

    5

    290 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey

     

    Comments

    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor